Acceptance and Commitment Therapy for Chemsex

Quasi-Randomized Controlled Trial of Acceptance and Commitment Therapy for Chemsex

Quasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.

Intervention will entail a prescreening, intake session, 16 therapy sessions, and a six-month follow-up. Each session will be 45-55 minutes long. Participants in ACT-for-chemsex will be compared to participants in a treatment as usual condition.

Inclusion Criteria:

• Male
• age 18-65
• access to internet capable smart device
• documentation of Alabama residence
• access to a private area to attend tele ACT-for-chemsex sessions
• self-reported chemsex within six-months of intake
• English fluency.

Exclusion Criteria:

• Psychotic disorder
• bipolar disorder
• eating disorder
• major neurocognitive disorder diagnosis
• self-harm or suicide attempt within 12 months of screener
• suicide plan/intention at time of screening
• ongoing treatment for a complex medical comorbidity (e.g., in patient cancer treatment)
• current enrollment in an individual ACT-based psychotherapy intervention.